Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Circular Rnas; Powerful Microrna Sponges to Overcome Diabetic Nephropathy Publisher Pubmed



Mafi A1 ; Yadegar N2 ; Salami M3 ; Salami R4 ; Vakili O1 ; Aghadavod E4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Medical Laboratory Sciences, School of Paramedical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Biochemistry, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
  4. 4. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
  5. 5. Department of Clinical Biochemistry, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran

Source: Pathology Research and Practice Published:2021


Abstract

Diabetic nephropathy (DN), also known as diabetic kidney disease (DKD), is a drastic renal complication of type 1 and type 2 diabetes mellitus (DM). Poorly controlled DM over the years, may disrupt kidneys’ blood vessels, leading to the hypertension (HTN) and DN onset. During DN, kidneys’ waste filtering ability becomes disturbed. Being on a healthy lifestyle and controlling both DM and HTN are now the best proceedings to prevent or at least delay DN occurrence. Unfortunately, about one-fourth of diabetic individuals eventually experience the corresponding renal failure, and thus it is critical to discover effective diagnostic biomarkers and therapeutic strategies to combat DN. In the past few years, circular RNAs (circRNAs), as covalently closed endogenous non-coding RNAs (ncRNAs), are believed to affect DN pathogenesis in a positive manner. CircRNAs are able to impact different cellular processes and signaling pathways by targeting biological molecules or various molecular mechanisms. Still, as a key regulatory axis, circRNAs can select miRNAs as their molecular targets, in which they are considered as miRNA sponges. In this way, circRNA-induced suppression of particular miRNAs may prevent from DN progression or promotes the DN elimination. Since the expression of circRNAs has also been reported to be increased in DN-associated cells and tissues, they can be employed as either diagnostic biomarkers or therapeutic targets. © 2021
Other Related Docs
10. Mir-802-5P Is a Key Regulator in Diabetic Kidney Disease, Journal of Research in Medical Sciences (2023)
24. Circular Rnas: New Genetic Tools in Melanoma, Biomarkers in Medicine (2020)
34. Circular Rnas-Mediated Angiogenesis in Human Cancers, Clinical and Translational Oncology (2023)
36. Role of Non-Coding Rnas in Osteoporosis, Pathology Research and Practice (2024)
48. Epigenetics and Common Non Communicable Disease, Advances in Experimental Medicine and Biology (2019)
49. Circular Rnas: A Small Piece in the Heart Failure Puzzle, Functional and Integrative Genomics (2024)